PIONEERING research on lung cancer by an Irish team has already produced "some exciting results" and may lead to new treatments.
The research, the first of its kind in the world, is being carried out at Trinity College and St James's Hospital in Dublin.
Lung cancer patients are 20 times more likely to have a blood clot than someone who is cancer-free and the team is looking at the link between blood clotting pathways and the cancer.
As part of their work the team, led by Professor Ken O'Byrne, have set up Ireland's first lung cancer bio-bank with over 650 samples collected from lung cancer patients at St James's.
Lung cancer is the main cause of cancer-related death in Ireland. It has a low response to treatment with only 12pc of patients surviving for more than five years.
The Irish Cancer Society, which is funding the research says "new therapies are therefore urgently required for the treatment of this disease".
Dr Mary Clare Cathcart, who is involved in the project, said: "We hope that this research will lead us to new therapies for lung cancer treatment.
"We have already made some important findings, which may help curb lung cancer development in 'at risk' patients, as well as exploring new treatment options which may increase the efficacy of conventional chemotherapy drugs."
More people die from lung cancer in Ireland each year than breast, colon and prostate cancer combined.